SCHEMBL3993531

SCHEMBL3993531

N#CN1CCCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3915599 0.97
SCHEMBL31439002 0.76 CTSL (0.35)
SCHEMBL3546430 0.75 CA2 (0.33)
SCHEMBL3549294 0.75 CA2 (0.33)
SCHEMBL3547679 0.75 CA2 (0.33)
SCHEMBL3546043 0.75 CA2 (0.33)
SCHEMBL2323466 0.75
Hydrochloric Acid SCHEMBL31439064 0.75 CTSL (0.33)
SCHEMBL16612338 0.72
SCHEMBL6005300 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114555053-A Methods of treating breast cancer 欧拉泰克治疗有限责任公司 2022-05-27 CN disclosed
CN-111867678-A Method for treating melanoma 欧拉泰克治疗有限责任公司 2020-10-30 CN disclosed
CN-111670032-A Methods for preventing or treating alzheimer's disease 欧拉泰克治疗有限责任公司 2020-09-15 CN disclosed
EP-1858509-A4 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LTD (GB) 2009-03-18 EP disclosed
EP-1858509-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LIMITED (GB) 2007-11-28 EP disclosed
WO-2006094003-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LIMITED (GB) 2006-09-08 WO disclosed